NCT02268773View on ClinicalTrials.gov

Effects of Acetylsalicylic Acid Compared With the Combination of Acetylsalicylic Acid + Modified-release Dipyridamole on Serum Thromboxane B2 Formation and Platelet Aggregation in Healthy Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

27

Participants

Timeline

Start Date

January 31, 2000

Primary Completion Date

May 31, 2000

Conditions
Healthy
Interventions
DRUG

Asasantin®

DRUG

Acetylsalicylic acid low dose

DRUG

Acetylsalicylic acid high dose

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY

NCT02268773 - Effects of Acetylsalicylic Acid Compared With the Combination of Acetylsalicylic Acid + Modified-release Dipyridamole on Serum Thromboxane B2 Formation and Platelet Aggregation in Healthy Volunteers | Biotech Hunter | Biotech Hunter